World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
22251
World Ranking
12390
National Ranking
670

Dirk Reinhardt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dirk Reinhardt sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 512 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dirk Reinhardt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dirk Reinhardt sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dirk Reinhardt is affiliated with the University of Duisburg-Essen in Germany and has a research focus spanning medicine and biochemistry, genetics, and molecular biology. Their extensive work covers various subfields including hematology, molecular biology, public health, environmental and occupational health, pediatrics, perinatology and child health, and cancer research.

Their research topics prominently feature acute myeloid leukemia, acute lymphoblastic leukemia, childhood cancer survivors' quality of life, hematopoietic stem cell transplantation, chronic myeloid leukemia treatments, cancer genomics and diagnostics, and extracellular vesicles in disease.

Recent publications by Dirk Reinhardt include:

  • The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets, 2021, Cancer Discovery
  • DNA in extracellular vesicles: from evolution to its current application in health and disease, 2022, Cell & Bioscience
  • Pediatric Acute Myeloid Leukemia-Past, Present, and Future, 2022, Journal of Clinical Medicine
  • Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG, 2021, Cancers
  • Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial, 2022, Leukemia

Frequent co-authors collaborating with Reinhardt include:

  • Nils von Neuhoff
  • Franco Locatelli
  • Evangelia Antoniou
  • Jan-Henning Klusmann
  • Katharina Waack

Reinhardt's contributions are published primarily in journals such as:

  • Blood
  • Cancers
  • Klinische Pädiatrie
  • MMW - Fortschritte der Medizin
  • HemaSphere

The range of their research outputs demonstrates engagement with both clinical and molecular perspectives on hematological malignancies, especially in pediatric oncology contexts. Their work on precision oncology registries and therapeutic agents relates closely to improving outcomes for high-risk pediatric cancer patients.

Best Publications

  • Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

    Ursula Creutzig;Marry M. van den Heuvel-Eibrink;Brenda Gibson;Michael N. Dworzak

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Clinical implications of FLT3 mutations in pediatric AML

    Soheil Meshinchi;Todd A. Alonzo;Derek L. Stirewalt;Michel Zwaan

  • Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson

  • The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Thomas B. Alexander;Thomas B. Alexander;Zhaohui Gu;Ilaria Iacobucci;Kirsten Dickerson

  • NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

    Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona

  • Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.

    Ursula Creutzig;M. Zimmermann;J. Ritter;D. Reinhardt

  • Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

    Barbara C. Worst;Barbara C. Worst;Cornelis M. van Tilburg;Gnana Prakash Balasubramanian;Petra Fiesel;Petra Fiesel

  • Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98

    Ursula Creutzig;Martin Zimmermann;Dirk Reinhardt;Michael Dworzak

  • Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

    Jan-Henning Klusmann;Ursula Creutzig;Martin Zimmermann;Michael Dworzak

  • Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

    B F Goemans;Ch M Zwaan;Ch M Zwaan;M Miller;M Zimmermann

  • Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

    Christine von Neuhoff;Dirk Reinhardt;Annette Sander;Martin Zimmermann

  • FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

    Christian M Zwaan;Soheil Meshinchi;Jerald P Radich;Anjo J P Veerman

  • Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    Tim Ripperger;Stefan S. Bielack;Arndt Borkhardt;Ines B. Brecht;Ines B. Brecht

  • Improved Treatment Results in High-Risk Pediatric Acute Myeloid Leukemia Patients After Intensification With High-Dose Cytarabine and Mitoxantrone: Results of Study Acute Myeloid Leukemia–Berlin-Frankfurt-Münster 93

    U Creutzig;J Ritter;M Zimmermann;D Reinhardt

  • miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia

    Jan-Henning Klusmann;Zhe Li;Katarina Böhmer;Aliaksandra Maroz

  • Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

    T Lehrnbecher;D Varwig;J Kaiser;D Reinhardt

  • Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

    Gertjan J. L. Kaspers;Martin Zimmermann;Dirk Reinhardt;Brenda E. S. Gibson

  • Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98

    Ursula Creutzig;Martin Zimmermann;Thomas Lehrnbecher;Norbert Graf

  • AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

    U Creutzig;D Reinhardt;S Diekamp;M Dworzak

Frequent Co-Authors

Martin Zimmermann
Martin Zimmermann Hannover Medical School
Michael Dworzak
Michael Dworzak Medical University of Vienna
Marry M. van den Heuvel-Eibrink
Marry M. van den Heuvel-Eibrink University Medical Center Utrecht
Rob Pieters
Rob Pieters Princess Máxima Center
André Baruchel
André Baruchel Hôpital Robert-Debré
Henrik Hasle
Henrik Hasle Aarhus University Hospital
Thomas Lehrnbecher
Thomas Lehrnbecher Goethe University Frankfurt
Jan Trka
Jan Trka Charles University
Todd A. Alonzo
Todd A. Alonzo University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open new career pathways in the healthcare field, especially if you’re interested in medicine but seeking alternative or flexible educational options. Accredited online programs are now available for many in-demand healthcare roles, offering convenience along with affordability.

One option is pursuing a him degree online, which prepares graduates for careers handling medical data and digital health information. Those interested in administrative support might consider medical coding certification programs. Both fields are essential for the smooth operation of healthcare institutions.

For those who want to provide direct patient care, online nurse practitioner programs can lead to advanced practice roles and greater responsibility. It’s also important to consider how much does online nursing school cost to make informed decisions about your education investment.

By comparing curriculum details, tuition costs, and certification pathways, you can choose an online degree that aligns with your professional goals in the ever-evolving world of healthcare.

Best Scientists Citing Dirk Reinhardt

Trending Scientists

Recently Published Articles